NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 3 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Recs

0
Player Avatar tableScraps (< 20) Submitted: 10/25/2008 6:14:33 AM : Outperform Start Price: $41.31 NUVA Score: -110.41

innovative product.

Featured Broker Partners


Advertisement